輝達(NVDA.US)計劃德國建首個工業應用AI雲平台
美國AI晶片巨擘輝達(NVDA.US)行政總裁黃仁勳表示,將在德國建立首個面向工業應用的AI雲平台。
黃仁勳在巴黎舉行的VivaTech會議上稱,英偉達正擴展七個歐洲國家建立人工智能技術中心的計劃,旨在與初創企業進行協作研究並建立人工智能生態系統。他又表示,歐盟規劃與其公司合作建立20座新人工智能工廠;此外,兩年內輝達將協助歐洲的人工智能計算能力提升十倍。
《路透》引述知情人士報道,黃仁勳周五(13日)將前往柏林,預計將會晤德國總理默茨。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.